-67%

est. 2Y upside i

HealthcareSeries C

Stride simplifies the complexities of being an independent worker by solving their biggest healthcare, savings & tax benefits challenges. Stride’s portable benefits system enables companies to contribute to individual workers’ benefits accounts while workers—regardless of their employment status—can manage on their own and take with them.

Rank

#3362

Sector

HealthTech, InsureTech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Stride Health operates in a large and growing market for independent worker benefits, evidenced by its 3.7M+ user base and strong partnerships with major gig platforms.

Last updated: March 10, 2026

Bull (15%)+150%

Stride successfully navigates regulatory changes and expands its tax and financial management tools, leveraging its 3.7M+ user base and strong partnerships. Annual revenue grows to $300M-$400M, leading to an acquisition by a major insurer or financial services firm at a premium valuation of $750M-$1.0B, yielding a +150% upside for common shareholders after accounting for the preference stack.

Base (50%)+25%

Stride maintains its market position in providing benefits for independent workers, with steady user growth and continued commission revenue from insurance enrollments. Annual revenue reaches $150M-$200M. The company is acquired at a modest premium or continues to operate privately, with a valuation of $250M-$300M, resulting in a +25% upside.

Bear (35%)-50%

Regulatory changes, particularly the expiration of enhanced Premium Tax Credits, significantly impact affordability for users, slowing enrollment growth. Increased competition from incumbents erodes market share and pricing power. Annual revenue stagnates or declines to $50M-$80M, leading to a down round or acquisition at a distressed valuation of $80M-$100M, where the $96M preference stack wipes out most common stock value, resulting in a -50% downside.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

45%

Investors hold $96M in liquidation preferences ahead of common shareholders, representing 45.2% of the current $213M valuation.

Dilution Risk

moderate

As a Series C company, further funding rounds are likely before an IPO or acquisition, posing moderate dilution risk for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Stride Health's equity.

Other — 2 roles

View all 2 open roles at Stride →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Stride's data — designed to show you've done your homework.

  • 1

    “How is Stride Health preparing to mitigate the impact of the expiring enhanced Premium Tax Credits for the 2026 Open Enrollment period, and what strategies are in place to maintain affordability for users?”

  • 2

    “Given the competitive landscape with players like eHealth and GoHealth, what are Stride's key differentiators beyond platform partnerships, and how do you plan to expand market share in the individual health and ancillary benefits segment?”

  • 3

    “With a Series C funding round in 2021, what is the anticipated timeline and preferred path to a liquidity event for employees, and how is the company managing potential future dilution?”

Community

Valuation Sentiment

Our model estimates -67% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.